Saturday, June 6, 2015

FDA Reviews Anti-Cholesterol Drugs

Two biotech cholesterol-lowering drugs, which could become blockbuster sellers, face scrutiny this week from health regulators.

from WSJ.com: US Business http://ift.tt/1FAh4Px
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)